Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Johnson and Johnson
Citi
Accenture
McKinsey
Chubb
Express Scripts
UBS
Julphar
Mallinckrodt

Generated: August 18, 2017

DrugPatentWatch Database Preview

Saralasin acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for saralasin acetate and what is the scope of saralasin acetate patent protection?

Saralasin acetate
is the generic ingredient in one branded drug marketed by Procter And Gamble and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: saralasin acetate

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list15
Clinical Trials: see list916
Patent Applications: see list1,327
Drug Prices:see low prices
DailyMed Link:saralasin acetate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Procter And Gamble
SARENIN
saralasin acetate
INJECTABLE;INJECTION018009-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: saralasin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Procter And Gamble
SARENIN
saralasin acetate
INJECTABLE;INJECTION018009-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Procter And Gamble
SARENIN
saralasin acetate
INJECTABLE;INJECTION018009-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Teva
Accenture
Argus Health
US Army
Cipla
Daiichi Sankyo
Chubb
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot